← Back to Analyst Consensus 
EWTX Buy
Edgewise Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 19
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 16, 2026 | William Blair | initiate | — → Outperform | — | 48% |
| Sep 21, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Aug 20, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Aug 11, 2026 | Goldman Sachs | maintain | Neutral → Neutral | — | 54% |
| Jul 20, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Jul 9, 2026 | Oppenheimer | initiate | — → Outperform | — | 52% |
| Jul 6, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Jun 17, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jun 17, 2026 | Goldman Sachs | maintain | Neutral → Neutral | — | 54% |
| Jun 16, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jun 2, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jun 2, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jun 2, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Mar 17, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Mar 17, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Feb 27, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | $45 | 58% |
| Nov 14, 2025 | JP Morgan | maintain | Overweight → Overweight | $34 | 55% |
| Nov 7, 2025 | RBC Capital | maintain | Outperform → Outperform | $50 | 55% |
| Nov 7, 2025 | Wedbush | maintain | Outperform → Outperform | $32 | 58% |
| Sep 25, 2025 | Goldman Sachs | initiate | — → Neutral | $20 | 54% |
| Aug 19, 2025 | JP Morgan | maintain | Overweight → Overweight | $30 | 55% |
| Aug 8, 2025 | RBC Capital | maintain | Outperform → Outperform | $49 | 55% |
| Jun 30, 2025 | HC Wainwright & Co. | initiate | — → Buy | $42 | 44% |
| Jun 5, 2025 | RBC Capital | reiterate | Outperform → Outperform | $48 | 55% |
| May 16, 2025 | JP Morgan | maintain | Overweight → Overweight | $40 | 55% |
| May 9, 2025 | RBC Capital | maintain | Outperform → Outperform | $48 | 55% |
| Apr 21, 2025 | Wedbush | maintain | Outperform → Outperform | $43 | 58% |
| Apr 3, 2025 | RBC Capital | maintain | Outperform → Outperform | $52 | 55% |
| Apr 3, 2025 | Scotiabank | downgrade | Sector Outperform → Sector Perform | $14 | 55% |
| Apr 2, 2025 | Piper Sandler | maintain | Overweight → Overweight | $51 | 54% |
| Mar 7, 2025 | Scotiabank | initiate | — → Sector Outperform | $50 | 55% |
| Mar 4, 2025 | RBC Capital | reiterate | Outperform → Outperform | $56 | 55% |
| Jan 22, 2025 | Stifel | initiate | — → Hold | $30 | 53% |
| Dec 17, 2024 | Evercore ISI Group | maintain | Outperform → Outperform | $50 | 58% |
| Nov 27, 2024 | Truist Securities | maintain | Buy → Buy | $50 | 54% |
| Nov 22, 2024 | Evercore ISI Group | initiate | — → Outperform | $45 | 58% |
| Nov 8, 2024 | Wedbush | maintain | Outperform → Outperform | $45 | 58% |
| Oct 11, 2024 | Piper Sandler | maintain | Overweight → Overweight | $51 | 54% |
| Sep 20, 2024 | RBC Capital | maintain | Outperform → Outperform | $42 | 55% |
| Sep 19, 2024 | Truist Securities | maintain | Buy → Buy | $33 | 54% |
| Sep 17, 2024 | RBC Capital | maintain | Outperform → Outperform | $32 | 55% |
| Aug 16, 2024 | Wedbush | reiterate | Outperform → Outperform | $31 | 58% |
| Aug 12, 2024 | JP Morgan | maintain | Overweight → Overweight | $31 | 55% |
| Jul 25, 2024 | RBC Capital | reiterate | Outperform → Outperform | $32 | 55% |
| Jul 10, 2024 | RBC Capital | reiterate | Outperform → Outperform | $32 | 55% |
| Jul 9, 2024 | JP Morgan | maintain | Overweight → Overweight | $30 | 55% |
| Jul 1, 2024 | Piper Sandler | maintain | Overweight → Overweight | $48 | 54% |
| Jun 26, 2024 | Wedbush | reiterate | Outperform → Outperform | $31 | 58% |
| Apr 22, 2024 | RBC Capital | maintain | Outperform → Outperform | $32 | 55% |
| Apr 17, 2024 | Truist Securities | maintain | Buy → Buy | $25 | 54% |
Price Target Trend
Jul 5, 2026 Oct 26, 2026
EPS Estimates
0y —
0q —
+1q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days